Heidelberg University

Overview

The Molecular Virology PhD research programme at Heidelberg University emphasizes the intricate mechanisms by which viruses replicate and interact with host cells, as well as the immune responses they trigger. This interdisciplinary programme prepares students to undertake groundbreaking research in the field of virology.

What you'll study

Central to the PhD programme is your unique research project, which is complemented by structured teaching and scientific training. Students will engage in a variety of learning activities designed to enhance their research and analytical skills.

• Core course topics may include:
• Molecular Virology
• Molecular Biology of Hepatitis B Viruses
• RNA Viruses: Replication and Innate Immune Response
• Research and professional development: Research Seminar – Molecular and Cell Biology of Viral Infections
• Practical and career-oriented training: Biolab and Working in Bioscience, Molecular Virology

Students typically participate in seminars, present their research progress, and develop experimental and analytical skills that align with their specific research topics.

Entry requirements

Applicants are expected to possess a master’s degree (or equivalent) with an above-average grade. The academic record should demonstrate at least four years of university-level study.

While specific GRE/GMAT or GPA thresholds are not mentioned, proficiency in English is essential. Accepted English language tests include:

• TOEFL iBT: minimum score of 90
• IELTS: minimum score of 6.5

Application materials typically required include a master’s degree certificate, academic transcripts, and English test results. Additional documents such as a CV, motivation letter, references, and research proposal may also be requested.

Career prospects

Graduates of the Molecular Virology PhD programme are well-prepared for a variety of career paths in academia, industry, and research institutions. They may pursue roles in scientific research, pharmaceuticals, biotechnology, or public health, contributing valuable insights into viral diseases and potential therapeutic targets.